Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Rhinocap*

Rhinocap* :
Type Medicine Non Marketed
Originator G
Agent Pharmaceutica
Distributor Pharmaceutica
Laboratory Dr Grossmann
Responsible Party Dr Grossmann AG Pharmaca
Origin Switzerland
Manufacturer Osmopharm for Dr Grossmann AG Pharmaca
Manufacturing Type G
Origin Switzerland
ATC R01BA53

Your comment will appear shortly after approval

Rhinocap* :

Revision Date : 01/03/2007


Effect Frequency
Accommodation disorder Uncommon
Agitation Rare
Arrhythmia Uncommon
Cephalea Rare
Confusion Rare
Dry mouth (Xerostomia) Uncommon
Hot flush Uncommon
Lightheadedness Uncommon
Nausea Uncommon
Nervousness Uncommon
Numbness Common
Ocular hypertension Uncommon
Skin Eruption Very rare
Somnolence Common
Tachycardia Uncommon

Different Units By MoH Code

Revision Date : 01/03/2007

Rhinocap*  MoH 4086 :
Form Controlled Release Capsules
Package Size Box of 10
Strength 25mg/10mg/20mg
NSSF ✘
Quarantine ✘
Reg. Number 23722/06
Submission date 01/01/2006
Registration Year 2006
Archived Date 02/03/2023


Price Comparison

● Country: Kuweit
● Package Size: Boîte de 10
● Public Price: 1.13 KWD ( 331,746.53 LBP )
● Pack size unit used: 10
● Cost/Unit: 0,113 KWD ( 0.00 LBP )
● Pharmacy Price: 0.96 KWD ( 281837.76 LBP )
● Pricing Date: 07/02/2021
● Type: Medicine Authorised

● Country: Oman
● Package Size: 10
● Public Price: 1.45 OMR ( 334,564.30 LBP )
● Pack size unit used: 10
● Cost/Unit: 0,145 OMR ( 0.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 10
● Public Price: 6.7 CHF ( 692,914.00 LBP )
● Pack size unit used: 10
● Cost/Unit: 0,67 CHF ( 0.00 LBP )
● Exfactory Price: 3.63 CHF
● Pricing Date: 20/06/2019
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info